Skip to main content

Headway Capital Partners’ advised fund HIP IV SCSp is delighted to have invested alongside TriSpan in the two assets described in the following press releases, on January 22, 2020 and July 13, 2021 respectively:


TriSpan to Acquire Majority Stake in PG Dental Holdings, LLC media/2019/06/PG-Dental-Press-Release-2019-06-03.pdf

The following press release outlines a subsequent merger, resulting in the launch of ProSmile on December 15, 2020:

PG Dental Holdings LLC and Allied Dental Holdings LLC Announce Successful Completion of Merger media/2020/12/PG-Dental-Press-Release-2020-12-01.pdf

Prestige PEO

TriSpan Provides Strategic Investment to Prestige PEO Holdings, LLC media/2021/01/PrestigePEO-TriSpan-Press-Release.pdf

About TriSpan, LLP
Founded in 2015, and with offices in New York and London, TriSpan is a private equity firm that invests in market-leading companies in North America, Europe, and the United Kingdom with annual revenues typically ranging $20 – $100 million and/or $2 – $20 million of EBITDA. TriSpan is committed to drive strong growth and performance by bringing deep operational and financial resources to bear in each of its investments. Since inception, the firm has invested in 17 platforms totaling more than 75 companies to date. For more information, please visit

About Headway Capital Partners
Headway Capital Partners is a London based private equity firm with advised funds of over €900 million. Headway provides bespoke liquidity and capital solutions to private equity GPs and managers, investing globally in a full range of secondary and co-investment transactions, with a focus on small to mid-size secondary direct, GP-led, and independent sponsor transactions in Europe and North America.